A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast Cancer
Patricia LoRusso, Erika Hamilton, X. Cynthia, Neelima Vidula, Rebecca G. Bagley, Steven Troy, Miriam Annett, Ziyang Yu, Maureen G. Conlan, Amy Weise
Topics & Concepts
MedicineTolerabilityAdverse effectInternal medicineMetastatic breast cancerSex hormone-binding globulinProstate cancerBreast cancerGastroenterologyCancerAndrogenHormoneAdvanced Breast Cancer TherapiesBreast Cancer Treatment StudiesProstate Cancer Treatment and Research